Single-Dose Bioequivalence Study of Rivaroxaban-Containing Medicinal Products in Healthy Volunteers

Single-Dose Bioequivalence Study of Rivaroxaban-Containing Medicinal Products in Healthy Volunteers

Therapeutically, new oral anticoagulants (NOACs) are considered to be non-inferior or superior to vitamin K antagonists (warfarin). NOACs are included in current guidelines for the treatment of various cardiovascular diseases. Rivaroxaban medicinal products have been shown to effectively fight throm...

Full description

Bibliographic Details
Main Authors:	G. N. Gildeeva, A. A. Chaplenko, V. I. Yurkov, E. S. Stepanova
Format:	Article
Language:	Russian
Published:	Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2022-10-01
Series:	Безопасность и риск фармакотерапии
Subjects:	rivaroxaban pharmacokinetics bioequivalence new oral anticoagulants safety profile
Online Access:	https://www.risksafety.ru/jour/article/view/316

Similar Items

NAT2 phenotype alters pharmacokinetics of rivaroxaban in healthy volunteers
by: Gonzalo Villapalos-García, et al.
Published: (2023-09-01)

Evaluation of Pharmacokinetics and Safety with Bioequivalence of Ibuprofen Sustained-Release Capsules of Two Formulations, in Chinese Healthy Volunteers: Bioequivalence Study
by: Huang C, et al.
Published: (2023-06-01)

Rivaroxaban in non valvular atrial fibrillation: subgroups analysis
by: Cesare Greco
Published: (2015-08-01)

Bioequivalence Study of Amitriptyline Hydrochloride Tablets in Healthy Chinese Volunteers Under Fasting and Fed Conditions
by: Zhai Y, et al.
Published: (2020-08-01)

Population Pharmacokinetics and Dose Optimization Based on Renal Function of Rivaroxaban in Thai Patients with Non-Valvular Atrial Fibrillation
by: Noppaket Singkham, et al.
Published: (2022-08-01)

Bioequivalence of levamlodipine besylate tablets in healthy Chinese subjects: a single-dose and two-period crossover randomized study
by: Xin Li, et al.
Published: (2020-11-01)

Pharmacokinetics and Bioequivalence of Two Formulations of Valsartan 80 mg Capsules: A Randomized, Single Dose, 4-Period Crossover Study in Healthy Chinese Volunteers Under Fasting and Fed Conditions
by: Wu Q, et al.
Published: (2020-10-01)

Application of rapid and simple liquid chromatography method for determination of bioequivalence of generic lamotrigine tablets in healthy Iranian volunteers
by: Samirasadat Abolmaali, et al.
Published: (2015-07-01)

Pharmacokinetics and Bioequivalence Evaluation of Two Montelukast Sodium Chewable Tablets in Healthy Chinese Volunteers Under Fasted and Fed Conditions
by: Li W, et al.
Published: (2021-03-01)

CHANGE OF ANTICOAGULANT EFFECT OF RIVAROXABAN DURING A DAY
by: I. V. Gel’Tser, et al.
Published: (2015-08-01)

Bioequivalence Study of Two Formulations of Tramadol Capsules in Healthy Myanmar Volunteers
by: Ye Htut Linn, et al.
Published: (2019-11-01)

Bioequivalence Study of Vortioxetine Hydrobromide Tablets in Healthy Chinese Subjects Under Fasting and Fed Conditions
by: Bai W, et al.
Published: (2023-09-01)

THE ADVANCED TACTICS OF THE MANAGEMENT OF PATIENTS WITH VENOUS THROMBOEMBOLISM: THE ROLE OF RIVAROXABAN AT VARIOUS STAGES OF TREATMENT
by: S. R. Gilyarevskiy
Published: (2016-06-01)

Bioequivalence Study Of A Fixed-Dose Combination Tablet Containing Melitracen 10 mg And Flupentixol 0.5 mg In Healthy Chinese Volunteers Under Fasted And Fed Conditions
by: Wu L, et al.
Published: (2019-09-01)

Bioequivalence study of a new sildenafil 100 mg orodispersible film compared to the conventional film-coated 100 mg tablet administered to healthy male volunteers
by: Radicioni M, et al.
Published: (2017-04-01)

Application of rapid and simple liquid chromatography method for determination of bioequivalence of generic lamotrigine tablets in healthy Iranian volunteers
by: Samira Sadat Abolmaali, et al.
Published: (2015-09-01)

Bioequivalence study of abacavir/lamivudine (600/300-mg) tablets in healthy Thai volunteers under fasting conditions
by: Ekawan Yoosakul, et al.
Published: (2016-02-01)

The Effect Of Food On The Pharmacokinetic Properties And Bioequivalence Of Two Formulations Of Levocetirizine Dihydrochloride In Healthy Chinese Volunteers
by: Cheng Y, et al.
Published: (2019-10-01)

Open questions on bioequivalence: the case of cholecalciferol
by: Antonio Marzo, et al.
Published: (2013-09-01)

Pharmacokinetics, Bioequivalence and Safety Evaluation of Two Ticagrelor Tablets Under Fasting and Fed Conditions in Healthy Chinese Subjects
by: Wang J, et al.
Published: (2021-03-01)

Oseltamivir phosphate for suspension is bioequivalent to TAMIFLU in healthy volunteers: a randomized, open-label clinical study
by: Ying Wang, et al.
Published: (2023-02-01)

Bioequivalence of two quetiapine extended release tablets in Chinese healthy volunteers under fasting and fed conditions and effects of food on pharmacokinetic profiles
by: Huang X, et al.
Published: (2018-12-01)

Pharmacogenetic Variants Associated with Fluoxetine Pharmacokinetics from a Bioequivalence Study in Healthy Subjects
by: Carlos Alejandro Díaz-Tufinio, et al.
Published: (2023-09-01)

Isolated hemopericardium after initiation of rivaroxaban: Implications and potential mechanisms
by: Adwait Mehta, et al.
Published: (2019-01-01)

Comparative pharmacokinetic evaluation and bioequivalence study of three different formulations of Imatinib Mesylate in CML patients
by: Ehsan Mohajeri, et al.
Published: (2016-02-01)

Dosing-time-dependent effect of rivaroxaban on coagulation activity in rats
by: Yuki Fujiwara, et al.
Published: (2017-08-01)

A study on the role of rivaroxaban in management of venous thromboembolism
by: Mohmed Abdalwahab, et al.
Published: (2015-10-01)

Recurrent Left Ventricular Thrombus Formation on Rivaroxaban Therapy in Cardiomyopathy and Liver Cirrhosis
by: Usman Ghani, MD, et al.
Published: (2020-08-01)

Comparative assessment of saliva and plasma for drug bioavailability and bioequivalence studies in humans
by: Nasir M. Idkaidek
Published: (2017-07-01)

Pharmacokinetics and bioequivalence of two cyclosporine oral solution formulations in cats
by: Yuxin Yang, et al.
Published: (2022-08-01)

Development of a UPLC-ESI-MS/MS method for the determination of triamcinolone acetonide in human plasma and evaluation of its bioequivalence after a single intramuscular injection in healthy volunteers
by: Pengfei Zhao, et al.
Published: (2023-07-01)

An open-label, randomized, cross-over bioequivalence study of montelukast 10 mg tablets in healthy Thai volunteers
by: Chaveewan Ratanajamit, et al.
Published: (2017-06-01)

A randomized, open-label study assessing the bioequivalence of two formulations of Fingolimod 0.5 mg in healthy subjects
by: Mario Tanguay, et al.
Published: (2018-03-01)

Comparative Effectiveness of Apixaban and Rivaroxaban Lead-in Dosing in VTE Treatment: Observational Multicenter Real-World Study
by: Omar A. Alshaya, et al.
Published: (2022-12-01)

Rivaroxaban in atrial fibrillation cardioversion: an update
by: Lavalle C, et al.
Published: (2019-05-01)

Pharmacokinetic and bioequivalence study comparing a fimasartan/rosuvastatin fixed-dose combination with the concomitant administration of fimasartan and rosuvastatin in healthy subjects
by: Kang WY, et al.
Published: (2018-10-01)

Is a Lower Dose of Rivaroxaban Required for Asians? A Systematic Review of a Population Pharmacokinetics and Pharmacodynamics Analysis of Rivaroxaban
by: Xiao-Qin Liu, et al.
Published: (2023-02-01)

Rivaroxaban in acute venous thromboembolism: UK prescribing experience
by: Victoria Speed, et al.
Published: (2021-10-01)

Bioequivalence study of a generic Risperidone (Iperdal®) in healthy Thai male volunteers
by: Werawath Mahatthanatrakul, et al.
Published: (2008-05-01)

Rivaroxaban Monotherapy in Patients with Pulmonary Embolism: Off-Label vs. Labeled Therapy
by: Pierpaolo Di Micco, et al.
Published: (2022-07-01)